Fidelity Select Health Care Portfolio FSPHX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 29.23  /  +0.44 %
  • Total Assets 6.8B
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.39%
  • Turnover 69%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 9:21 PM GMT+0

Morningstar’s Analysis FSPHX

Will FSPHX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still an exceptional source of healthcare exposure for the long term.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FSPHX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 40.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

7.66 483M
Healthcare

Danaher Corp

6.75 425M
Healthcare

Thermo Fisher Scientific Inc

6.34 399M
Healthcare

UnitedHealth Group Inc

4.21 265M
Healthcare

Johnson & Johnson

3.83 241M
Healthcare

AbbVie Inc

3.59 226M
Healthcare

argenx SE ADR

2.11 133M
Healthcare

Merck & Co Inc

2.11 133M
Healthcare

West Pharmaceutical Services Inc

2.09 132M
Healthcare

Ascendis Pharma AS

1.94 122M
Healthcare

Sponsor Center